Trending Now
Heat Biologics Inc. (NASDAQ:HTBX) Regains Its Continued Listing on the NASDAQ...
Heat Biologics Inc. (NASDAQ:HTBX) has regained its listing on the Nasdaq Stock Market. This was confirmed through a letter from the Listing Qualifications Department...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Maxar Stock (MAXR) could continue surging with increased interest from retail...
Maxar Technologies Inc (NYSE: MAXR) surged more than 100% on Friday after Advent agreed to acquire all outstanding shares of Maxar common...
MAKE IT MODERN
LATEST REVIEWS
Vericel Corporation Inc. (NASDAQ:VCEL) Posts Net Revenue Of $32.3 Million In...
Vericel Corporation Inc. (NASDAQ:VCEL) has announced its Q3 2020 financial results posting net revenue of $32.3 million and also provided business updates.
Vericel reports total...
MAKE IT MODERN
PERFORMANCE TRAINING
Anavex Life Sciences Corp (NASDAQ:AVXL) Receives SAS Approval For ANAVEX2-73 To Treat Patients With...
The Australian GDH (Government Department of Health) – TGA (Therapeutic Goods Administration) granted SAS (Special Access Scheme) approval Anavex2-73 of Anavex Life Sciences Corp...
Bitcoin Stocks for the Win (SQ, RIOT, ISWH, HVBTF)
The Cryptocurrency space is on fire once again as the price of Bitcoin rages to new all-time highs, flying higher in recent days to...
InflaRX N.V. (NASDAQ: IFRX) Announce Encouraging Data From Cohort 3 of the Phase IIaVilobelimab...
InflaRX N.V. (NASDAQ: IFRX) has announced positive findings from the third group of patients in the phase IIa open-label trial with vilobelimab in treating...
Amarin Corporation plc (NASDAQ:AMRN) says it is Supporting Investigator-Initiated Trial Evaluating the Effects of...
The current understanding of the biology of COVID-19 is that patients with atherosclerotic cardiovascular disease (ASCVD) have a higher risk of infection. However, the...
Novavax, Inc. (NASDAQ: NVAX) Received Marketing Authorization From the Swissmedic
Novavax, Inc. (NASDAQ: NVAX) has received conditional marketing authorisation from the Swissmedic for Nuvaxovid. This compound is a vaccine against COVID-19 in people aged...
MAKE IT MODERN
